| |
| |
|
| Insider
Information: |
Dolsten Mikael |
| Relationship: |
Director |
| City: |
Madison |
| State: |
NJ |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
327,440 |
|
|
Indirect Shares
|
1,981 |
|
|
| Direct
Value |
$9,598,773 |
|
|
|
Indirect Value
|
$54,537 |
|
|
| Total
Shares |
329,421 |
|
|
| Total
Value |
$9,653,310 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
3
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
3
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
-3.0
|
| Percentage
Gain/Loss : |
0.0%
|
 -16.6%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Pfizer Inc |
PFE |
President R&D |
2024-02-28 |
321,729 |
2024-02-28 |
1,981 |
Premium* |
|
|
Agilent Technologies Inc |
A |
Director |
2024-03-15 |
5,711 |
2021-09-22 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
61 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 3
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| A |
Agilent Technologies Inc |
Director |
• • – |
2021-09-22 |
4 |
A |
$172.44 |
$97,773 |
D/D |
567 |
567 |
0 |
- |
|
| A |
Agilent Technologies Inc |
Director |
– • – |
2023-03-16 |
4 |
A |
$136.82 |
$226,848 |
D/D |
1,658 |
4,018 |
0 |
- |
|
| A |
Agilent Technologies Inc |
Director |
• • – |
2024-03-15 |
4 |
A |
$147.48 |
$247,471 |
D/D |
1,678 |
5,711 |
0 |
- |
|
| A |
Agilent Technologies Inc |
Director |
• • – |
2022-03-17 |
4 |
A |
$136.82 |
$244,224 |
D/D |
1,785 |
2,352 |
0 |
- |
|
| PFE |
Pfizer Inc |
President R&D |
• • – |
2016-02-28 |
4 |
D |
$30.23 |
$288,666 |
D/D |
(9,549) |
435,210 |
0 |
- |
|
| PFE |
Pfizer Inc |
President R&D |
• • – |
2018-03-02 |
4 |
S |
$35.85 |
$501,398 |
D/D |
(13,986) |
120,884 |
0 |
- |
|
| PFE |
Pfizer Inc |
President R&D |
• • – |
2016-02-28 |
4 |
A |
$0.00 |
$0 |
D/D |
18,530 |
444,759 |
0 |
- |
|
| PFE |
Pfizer Inc |
President R&D |
• • – |
2024-02-28 |
4 |
D |
$27.04 |
$579,656 |
D/D |
(21,437) |
321,729 |
0 |
- |
|
| PFE |
Pfizer Inc |
President R&D |
• • – |
2015-02-25 |
4 |
A |
$0.00 |
$0 |
D/D |
23,006 |
525,313 |
0 |
- |
|
| PFE |
Pfizer Inc |
President R&D |
• • – |
2021-02-27 |
4 |
D |
$33.49 |
$798,435 |
D/D |
(23,841) |
137,727 |
0 |
- |
|
| PFE |
Pfizer Inc |
President R&D |
• • – |
2024-02-23 |
4 |
D |
$27.76 |
$689,059 |
D/D |
(24,822) |
343,166 |
0 |
- |
|
| PFE |
Pfizer Inc |
President R&D |
• • – |
2021-02-25 |
4 |
D |
$33.82 |
$956,125 |
D/D |
(28,271) |
156,568 |
0 |
- |
|
| PFE |
Pfizer Inc |
President R&D |
• • – |
2021-02-25 |
4/A |
D |
$33.82 |
$956,125 |
D/D |
(28,271) |
161,568 |
0 |
- |
|
| PFE |
Pfizer Inc |
President R&D |
• • – |
2014-02-26 |
4 |
D |
$31.99 |
$921,056 |
D/D |
(28,792) |
351,445 |
0 |
- |
|
| PFE |
Pfizer Inc |
President R&D |
• • – |
2014-02-27 |
4 |
A |
$0.00 |
$0 |
D/D |
28,915 |
380,360 |
0 |
- |
|
| PFE |
Pfizer Inc |
President R&D |
• • – |
2022-02-26 |
4 |
D |
$47.72 |
$1,419,384 |
D/D |
(29,744) |
294,118 |
0 |
- |
|
| PFE |
Pfizer Inc |
President R&D |
• • – |
2022-02-23 |
4 |
D |
$46.87 |
$1,395,179 |
D/D |
(29,767) |
323,862 |
0 |
- |
|
| PFE |
Pfizer Inc |
President R&D |
• • – |
2013-03-06 |
4 |
S |
$28.11 |
$859,798 |
D/D |
(30,582) |
304,921 |
0 |
- |
|
| PFE |
Pfizer Inc |
President R&D |
• • – |
2017-02-27 |
4 |
A |
$0.00 |
$0 |
D/D |
31,800 |
172,115 |
0 |
- |
|
| PFE |
Pfizer Inc |
President R&D |
• • – |
2013-02-28 |
4 |
D |
$27.37 |
$891,304 |
D/D |
(32,565) |
335,503 |
0 |
- |
|
| PFE |
Pfizer Inc |
President R&D |
• • – |
2023-02-22 |
4 |
D |
$42.38 |
$1,381,249 |
D/D |
(32,592) |
391,223 |
0 |
- |
|
| PFE |
Pfizer Inc |
President R&D |
• • – |
2017-02-27 |
4 |
D |
$34.28 |
$1,130,589 |
D/D |
(32,981) |
132,479 |
0 |
- |
|
| PFE |
Pfizer Inc |
President R&D |
• • – |
2014-03-04 |
4 |
S |
$32.57 |
$1,165,929 |
D/D |
(35,789) |
344,571 |
0 |
- |
|
| PFE |
Pfizer Inc |
Senior Vice President |
• – – |
2010-02-25 |
4 |
A |
$0.00 |
$0 |
D/D |
36,212 |
137,987 |
0 |
- |
|
| PFE |
Pfizer Inc |
President R&D |
• • – |
2023-02-25 |
4 |
D |
$41.75 |
$1,548,007 |
D/D |
(37,078) |
354,145 |
0 |
- |
|
61 Records found
|
|
Page 1 of 3 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
